These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9988614)

  • 1. Acute reaction to dipyridamole during myocardial scintigraphy.
    Angelides S; Van der Wall H; Freedman SB
    N Engl J Med; 1999 Feb; 340(5):394. PubMed ID: 9988614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe bradyarrhythmia during myocardial perfusion scintigraphy with injection of dipyridamole (Persantine)].
    Bielen M; Karsera D; Mélon P; Kulbertus H
    Rev Med Liege; 1999 Feb; 54(2):105-8. PubMed ID: 10221063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dipyridamole Tc-99m MIBI myocardial perfusion scintigraphy in patients with post-infarction chest pain symptom].
    Yang CC; Wu CC; Jong SB
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):605-17. PubMed ID: 1296041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The analysis of negative studies in myocardial perfusion scintigraphy].
    Bronze L; Ferreira J; Santos L; Trabulo M; Gil V; Seabra-Gomes R
    Rev Port Cardiol; 1995 Nov; 14(11):863-6. PubMed ID: 8541065
    [No Abstract]   [Full Text] [Related]  

  • 5. The VEX-test for myocardial scintigraphy with thallium-201 and sestamibi: effect on abdominal background activity.
    Hurwitz GA; Saddy S; O'Donoghue JP; Ali SA; Powe JE; Husni M; Gravelle DR
    J Nucl Med; 1995 Jun; 36(6):914-20. PubMed ID: 7769446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Whole body distribution of Tc-99m-sestamibi after pharmacological stress with arbutamine and dipyridamole compared with resting conditions].
    Kotzerke J; Bergmann K; Glatz S; Höher M; Reske SN
    Nuklearmedizin; 1997 Jan; 36(1):19-22. PubMed ID: 9082336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous dipyridamole technetium-99m MMI myocardial perfusion scintigraphy for detection of coronary artery disease.
    Yang CC; Wu CC; Jong SB; Shen LH; Wey SP; Ting G
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Feb; 8(2):59-74. PubMed ID: 1404526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole technetium-99m Sestamibi imaging in the diagnosis of syndrome X.
    Palleschi L; Gianni W; De Vincentis G; Banci M; Sottosanti G; Ierardi M; Scopinaro F; Marigliano V
    Angiology; 1996 Apr; 47(4):369-73. PubMed ID: 8619509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECG of the month. Chest tightness and electrocardiographic changes during a dipyridamole-technetium-99m-sestamibi myocardial perfusion study. Myocardial ischemia.
    Glancy DL; Smith JM; Wilklow FE; Lewis RS
    J La State Med Soc; 2007; 159(3):123-5. PubMed ID: 17694930
    [No Abstract]   [Full Text] [Related]  

  • 10. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
    Flamen P; Bossuyt A; Franken PR
    J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary uptake of technetium-99m-sestamibi induced by dipyridamole-based stress or exercise.
    Hurwitz GA; Ghali SK; Husni M; Slomka PJ; Mattar AG; Reid RH; Lefcoe NM
    J Nucl Med; 1998 Feb; 39(2):339-45. PubMed ID: 9476947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison between technetium-99m-sestamibi and thallium-201 tomographic imaging for the detection of coronary artery disease using combined dipyridamole-exercise stress.
    Cramer MJ; Verzijlbergen JF; Van der Wall EE; Niemeyer MG; Zwinderman AH; Ascoop CA; Pauwels EJ
    Coron Artery Dis; 1994 Sep; 5(9):787-91. PubMed ID: 7858770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of normal technetium-99m-sestamibi cardiac imaging.
    Brown KA; Altland E; Rowen M
    J Nucl Med; 1994 Apr; 35(4):554-7. PubMed ID: 8151374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous dipyridamole and adenosine Tc-99m MIBI myocardial imaging for detection of coronary artery disease.
    Yang CC; Jong SB; Chen UW; Lee BF; Wu CN
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Feb; 10(2):68-76. PubMed ID: 8176773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of myocardial ischemia: value of combined myocardial perfusion and cineangiographic MR imaging.
    Hartnell G; Cerel A; Kamalesh M; Finn JP; Hill T; Cohen M; Tello R; Lewis S
    AJR Am J Roentgenol; 1994 Nov; 163(5):1061-7. PubMed ID: 7976875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of myocardial viability by sestamibi scintigraphy.
    De Geeter F
    J Nucl Med; 1994 May; 35(5):921-2. PubMed ID: 8176483
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of dipyridamole Tc-99m myocardial imaging with dipyridamole electrocardiogram in detecting coronary artery disease].
    Yang ZJ; Wang JY; Gao BS
    Zhonghua Nei Ke Za Zhi; 1993 Nov; 32(11):736-8. PubMed ID: 8137651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Planar myocardial scintigraphy with technetium-99m-sestamibi in acute myocardial infarct treated with thrombolytic therapy].
    Zammarchi A; Pitscheider W; Mautone A; Oberhollenzer R; Lintner W; Erlicher A; Crepaz R; Osele L; Braito E
    G Ital Cardiol; 1995 Aug; 25(8):1011-9. PubMed ID: 7498619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thallium 201 myocardial scintigraphy following dipyridamole infusion].
    Laarman GJ; Verzijlbergen JF; Klein B; Ascoop CA
    Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1941-4. PubMed ID: 3774042
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular function and myocardial perfusion during dipyridamole infusion assessed by a single injection of 99Tcm-sestamibi in patients unable to exercise.
    Takeishi Y; Sukekawa H; Saito H; Nishimura S; Shibu T; Sasaki Y; Tomoike H
    Nucl Med Commun; 1994 Sep; 15(9):697-703. PubMed ID: 7816382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.